Hsing‐Lin Lai

1.2k total citations
29 papers, 962 citations indexed

About

Hsing‐Lin Lai is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Hsing‐Lin Lai has authored 29 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Hsing‐Lin Lai's work include Cellular transport and secretion (7 papers), Adenosine and Purinergic Signaling (7 papers) and Genetic Neurodegenerative Diseases (5 papers). Hsing‐Lin Lai is often cited by papers focused on Cellular transport and secretion (7 papers), Adenosine and Purinergic Signaling (7 papers) and Genetic Neurodegenerative Diseases (5 papers). Hsing‐Lin Lai collaborates with scholars based in Taiwan, Italy and United States. Hsing‐Lin Lai's co-authors include Yijuang Chern, Huimei Chen, Yi‐Chao Lee, Chen Chang, Ming‐Chang Chiang, Jiun‐Tsai Lin, Chuen‐Lin Huang, Klim King, Liming Lee and Ting‐Hui Lin and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Hsing‐Lin Lai

29 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsing‐Lin Lai Taiwan 20 580 376 268 197 106 29 962
Rita Pepponi Italy 21 499 0.9× 438 1.2× 374 1.4× 110 0.6× 109 1.0× 46 1.1k
Fernando Pérez‐Cerdá Spain 14 395 0.7× 493 1.3× 238 0.9× 141 0.7× 108 1.0× 21 1.4k
Yuxiang Xie United States 16 735 1.3× 632 1.7× 83 0.3× 291 1.5× 259 2.4× 18 1.5k
Adam Gorlewicz Poland 12 406 0.7× 439 1.2× 90 0.3× 48 0.2× 145 1.4× 17 904
Nicol Birsa United Kingdom 15 786 1.4× 153 0.4× 58 0.2× 265 1.3× 143 1.3× 17 1.1k
Elisabetta Babetto United States 16 620 1.1× 760 2.0× 60 0.2× 225 1.1× 241 2.3× 24 1.4k
Till G.A. Mack Germany 16 670 1.2× 684 1.8× 79 0.3× 216 1.1× 371 3.5× 21 1.5k
Mandi Gandelman United States 12 278 0.5× 190 0.5× 115 0.4× 341 1.7× 124 1.2× 17 732
Xavier Xifró Spain 22 638 1.1× 635 1.7× 34 0.1× 284 1.4× 125 1.2× 36 1.1k
E. Dux Hungary 21 610 1.1× 458 1.2× 103 0.4× 98 0.5× 242 2.3× 39 1.2k

Countries citing papers authored by Hsing‐Lin Lai

Since Specialization
Citations

This map shows the geographic impact of Hsing‐Lin Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing‐Lin Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing‐Lin Lai more than expected).

Fields of papers citing papers by Hsing‐Lin Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsing‐Lin Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing‐Lin Lai. The network helps show where Hsing‐Lin Lai may publish in the future.

Co-authorship network of co-authors of Hsing‐Lin Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Hsing‐Lin Lai. A scholar is included among the top collaborators of Hsing‐Lin Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsing‐Lin Lai. Hsing‐Lin Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chien‐Yu, Hsing‐Lin Lai, Huimei Chen, et al.. (2019). Functional roles of ST8SIA3-mediated sialylation of striatal dopamine D2 and adenosine A2A receptors. Translational Psychiatry. 9(1). 209–209. 20 indexed citations
3.
Weng, Yu‐Ting, Hsing‐Lin Lai, Feng‐Lan Chiu, et al.. (2018). GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons. Molecular Psychiatry. 23(12). 2375–2390. 29 indexed citations
4.
Lee, Chia‐Chia, Ching‐Pang Chang, Chun‐Jung Lin, et al.. (2018). Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease. Molecular Neurobiology. 55(12). 8936–8952. 45 indexed citations
5.
Chen, Chien‐Chang, Hsing‐Lin Lai, Si‐Tse Jiang, et al.. (2017). The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic stress by a PKA/STAT3-dependent pathway. Journal of Biomedical Science. 24(1). 68–68. 13 indexed citations
6.
Kao, Yu-Han, Chiung‐Mei Chen, Yih‐Ru Wu, et al.. (2016). Targeting ENT1 and adenosine tone for the treatment of Huntington’s disease. Human Molecular Genetics. 26(3). ddw402–ddw402. 32 indexed citations
8.
Ju, Tz‐Chuen, Hui‐Mei Chen, Liming Lee, et al.. (2014). Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis. Human Molecular Genetics. 24(3). 787–801. 58 indexed citations
9.
Lai, Hsing‐Lin, et al.. (2013). A novel Gαs-binding protein, Gas-2 like 2, facilitates the signaling of the A 2A adenosine receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 3145–3154. 9 indexed citations
10.
Lai, Hsing‐Lin, et al.. (2013). Lack of type VI adenylyl cyclase (AC6) leads to abnormal sympathetic tone in neonatal mice. Experimental Neurology. 248. 10–15. 3 indexed citations
11.
Huang, Nai‐Kuei, Jung‐Hsin Lin, Jiun‐Tsai Lin, et al.. (2011). A New Drug Design Targeting the Adenosinergic System for Huntington's Disease. PLoS ONE. 6(6). e20934–e20934. 65 indexed citations
12.
Lai, Hsing‐Lin, et al.. (2010). Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6). FEBS Letters. 584(13). 2883–2890. 31 indexed citations
13.
Cheng, Hsiao‐Chun, Shen‐Yang Lee, Ya‐Wen Lin, et al.. (2006). Rescue of p53 Blockage by the A2A Adenosine Receptor via a Novel Interacting Protein, Translin-Associated Protein X. Molecular Pharmacology. 70(2). 454–466. 50 indexed citations
14.
Chou, Szu‐Yi, Yi‐Chao Lee, Hui‐Mei Chen, et al.. (2005). CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. Journal of Neurochemistry. 93(2). 310–320. 141 indexed citations
15.
Huang, Chuen‐Lin, et al.. (2004). Regulation of Type VI Adenylyl Cyclase by Snapin, a SNAP25-binding Protein. Journal of Biological Chemistry. 279(44). 46271–46279. 40 indexed citations
16.
Lee, Yi‐Chao, Chuen‐Lin Huang, Nai‐Kuei Huang, et al.. (2003). Characterization of the rat A2A adenosine receptor gene: a 4.8‐kb promoter‐proximal DNA fragment confers selective expression in the central nervous system. European Journal of Neuroscience. 18(7). 1786–1796. 50 indexed citations
17.
Lai, Hsing‐Lin, et al.. (2001). N-Glycosylation and Residues Asn805 and Asn890 Are Involved in the Functional Properties of Type VI Adenylyl Cyclase. Journal of Biological Chemistry. 276(38). 35450–35457. 29 indexed citations
18.
Huang, Chuen‐Lin, Hạixia Chen, Nai‐Kuei Huang, et al.. (1999). Modulation of Dopamine Transporter Activity by Nicotinic Acetylcholine Receptors and Membrane Depolarization in Rat Pheochromocytoma PC12 Cells. Journal of Neurochemistry. 72(6). 2437–2444. 17 indexed citations
19.
Lai, Hsing‐Lin, et al.. (1999). The N Terminus Domain of Type VI Adenylyl Cyclase Mediates Its Inhibition by Protein Kinase C. Molecular Pharmacology. 56(3). 644–650. 38 indexed citations
20.
Chern, Yijuang, et al.. (1992). Molecular Cloning of a Novel Adenosine Receptor Gene from Rat Brain. Biochemical and Biophysical Research Communications. 185(1). 304–309. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026